(Hypertension. 1996;28:196-201.)
© 1996 American Heart Association, Inc.
Articles |
Characterization of the Renal Phenotype of Transgenic Rats Expressing the Human Endothelin-2 Gene
the Department of Nephrology, Universitatsklinikum Charite (B.H.); Universitatsklinikum Benjamin Franklin (L.L., A.D.); Institute of Molecular Biology and Biochemistry (B.H., C.T.-R., C.B.); and Institute of Clinical Pharmacology (L.L., H.-D.O., M.P.), Freie Universitat Berlin (Germany).
Correspondence to Prof Dr Martin Paul, Inst. fur Klin. Pharmakologie, Universitatsklinikum Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, FRG. E-mail paul@ukbf.fu-berlin.de.
We have previously established a transgenic rat model termed TGR(hET-2)37 overexpressing the human endothelin-2 (ET-2) gene with high renal transgene expression. This renal overexpression is of pathophysiological interest because a long-term activated paracrine renal endothelin system has been implicated in chronic renal failure due to progressive glomerular injury. Therefore, our aim in the present study was to analyze renal transgene expression in detail and address the question of whether transgene expression causes phenotypic and functional changes in the kidney. We used reverse transcription-polymerase chain reaction and in situ hybridization techniques for transgene expression analysis. Tissue ET-2 concentrations were measured with a specific radioimmunoassay. For histological evaluation of renal tissue, all samples were subjected to hematoxylin-eosin and periodic acid-Schiff staining. Renal tissue ET-2 concentrations were significantly increased in TGR(hET-2)37 rats. Using in situ hybridization, we found that the human ET-2 gene was almost exclusively expressed within the glomeruli. The glomerular transgene expression resulted in a significantly increased glomerular injury score and likewise in a significantly increased protein excretion, whereas glomerular filtration rate was not altered. Blood pressure was similar in TGR(hET-2)37 rats and age-matched controls, suggesting that the local changes in the kidney were correlated with paracrine endothelin actions. In conclusion, our study revealed that the major renal expression site of the human ET-2 transgene in TGR(hET-2)37 rats was within the glomeruli and caused the development of glomerulosclerosis with significantly increased protein excretion that is independent of blood pressure. We suggest that TGR(hET-2)37 rats are a new monogenetic animal model for study of the paracrine renal endothelin system and its involvement in renal pathophysiology.
Key Words: human • endothelins • rats, transgenic • kidney • glomerular sclerosis • blood pressure
This article has been cited by other articles:
 |
|
 |
|
  T. Quaschning, F. Voss, K. Relle, P. Kalk, N. Vignon-Zellweger, T. Pfab, C. Bauer, F. Theilig, S. Bachmann, A. Kraemer-Guth, et al. Lack of Endothelial Nitric Oxide Synthase Promotes Endothelin-Induced Hypertension: Lessons from Endothelin-1 Transgenic/Endothelial Nitric Oxide Synthase Knockout Mice J. Am. Soc. Nephrol., March 1, 2007; 18(3): 730 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Uchide and K. Saida Primary structure of cat preproendothelin-2 and cat renal mRNA expression of preproendothelin-1 and preproendothelin-2 in naturally occurring renal failure. Experimental Biology and Medicine, June 1, 2006; 231(6): 997 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pfab, C. Thone-Reineke, F. Theilig, I. Lange, H. Witt, C. Maser-Gluth, M. Bader, J.-P. Stasch, P. Ruiz, S. Bachmann, et al. Diabetic Endothelin B Receptor-Deficient Rats Develop Severe Hypertension and Progressive Renal Failure J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1082 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lazar, C. Moreno, H. J. Jacob, and A. E. Kwitek Impact of genomics on research in the rat Genome Res., December 1, 2005; 15(12): 1717 - 1728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Pinto-Sietsma, S.-M. Herrmann, K. Schmidt-Petersen, T. Niu, H. L. Hillege, W. M.T. Janssen, D. de Zeeuw, P. de Jong, and R. Kreutz Role of the Endothelin-1 Gene Locus for Renal Impairment in the General Nondiabetic Population J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2596 - 2602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Quaschning, S. Kocak, C. Bauer, H.-H. Neumayer, J. Galle, and B. Hocher Increase in nitric oxide bioavailability improves endothelial function in endothelin-1 transgenic mice Nephrol. Dial. Transplant., March 1, 2003; 18(3): 479 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. DUSSAULE, P.-L. THARAUX, J.-J. BOFFA, F. FAKHOURI, R. ARDAILLOU, and C. CHATZIANTONIOU Mechanisms Mediating the Renal Profibrotic Actions of Vasoactive Peptides in Transgenic Mice J. Am. Soc. Nephrol., November 1, 2000; 11(90002): S124 - S128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Hocher and M. Paul Transgenic animal models for the analysis of the renal endothelin system Nephrol. Dial. Transplant., July 1, 2000; 15(7): 935 - 937. [Full Text] [PDF]
|
|
|
|
|
|
S. MORGERA, S. KUCHINKE, K. BUDDE, A. LUN, B. HOCHER, and H.-H. NEUMAYER Volume Stress-Induced Peritoneal Endothelin-1 Release in Continuous Ambulatory Peritoneal Dialysis J. Am. Soc. Nephrol., December 1, 1999; 10(12): 2585 - 2590. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Hocher, I. George, J. Rebstock, A. Bauch, A. Schwarz, H.-H. Neumayer, and C. Bauer Endothelin System–Dependent Cardiac Remodeling in Renovascular Hypertension Hypertension, March 1, 1999; 33(3): 816 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Orth, J. P. Esslinger, K. Amann, U. Schwarz, M. Raschack, and E. Ritz Nephroprotection of an ETA-Receptor Blocker (LU 135252) in Salt-Loaded Uninephrectomized Stroke-Prone Spontaneously Hypertensive Rats Hypertension, April 1, 1998; 31(4): 995 - 1001. [Abstract] [Full Text] [PDF]
|
|